Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis

Go back to Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
Aceto Corp (NASDAQ: ACET) Delayed: 3.99 -0.29 (6.78%)
Previous Close $4.28    52 Week High $28.54 
Open $4.22    52 Week Low $15.69 
Day High $4.29    P/E 3.59 
Day Low $3.96    EPS $1.11 
Volume 162,965